About BreathDX

Founded by Professor Tony Killard, BreathDX is a UK-based company located in the growing bio-medical hub of South West England. Professor Killard is the principal inventor of AmBeR®

He is Professor of Biomedical Sciences at the University of the West of England and Adjunct Professor at the Biomedical Diagnostics Institute in Dublin City University where the technology was developed. He has dedicated a significant part of his work to designing and developing the device.

The highly experienced BreathDX team has already secured UK device-to-market funding, and AmBeR® is being brought to market with UK funding of more than €1 million. Dublin City University licensed the AmBeR® technology to BreathDX in  August 2015 and also holds an equity stake in the company.

About AmBeR®

AmBeR® is a new ammonia in-breath measurement device. Designed to diagnose and manage a range of conditions it offers a simple, quick and accurate alternative to blood tests.

AmBeR® has the potential to revolutionise the standard of care for patients and their families, and at the same time provides the ultimate cost effective solution for effective disease management for healthcare providers.

Practical • Painless • Precise • Portable


What is AmBeR®?

Find out more...

What is AmBeR® Clinical?

Find out more...